The recent wildfires in Los Angeles are just the latest in a series of natural disasters that have disrupted cancer care.

Further assessment is needed to understand if these treatment recommendations were eventually adopted and if adoption leads to better outcomes,” researchers wrote.

The FDA has authorized an expanded access program that will allow for the use of a recombinant bacillus Calmette-Guerin product.

Tremtelectogene empogeditemcel (trem-cel) may make gemtuzumab ozogamicin maintenance safer for patients with high-risk acute myeloid leukemia (AML), according to results of a phase 1/2 trial presented ...

The proportion of patients achieving a prostate-specific antigen nadir less than or equal to 0.2 ng/ml was exactly the same for patients treated with transdermal estradiol patches and those ...

NSAID use is associated with an increased risk of death from RCC among women but not among men, researchers found.

Although there was a significant decline in the age-adjusted incidence-based mortality rate from 2006 to 2020, our study did not show a significant improvement in survival outcomes,” the researchers ...

The FDA has approved the biologics license applications for Ospomyv and Xbryk, biosimilars to Prolia and Xgeva, respectively.

(HealthDay News) — Overdiagnosis of thyroid cancer remains a persistent problem in the United States, researchers reported in The Lancet Diabetes & Endocrinology.

Consuming a lower-fat diet and taking a fish oil supplement daily reduced the Ki-67 index in patients with prostate cancer on active surveillance.